Background-Prior studies have demonstrated differences in time to reperfusion for ST-segment-elevation myocardial infarction (STEMI) in women, minorities, and the elderly, relative to their counterparts. Regionalization has been shown to improve overall STEMI treatment times, but its impact on care differences among these important patient subgroups is unknown. The objective of this analysis was to assess the impact of a statewide system of STEMI care (The Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments) on treatment times according to patient sex, race, and age. Methods and Results-STEMI treatment times were determined before (a year-long implementation of coordinated regional treatment protocols. Times in the pre-and postintervention periods were compared by mixed-effects models. A total of 2063 STEMI patients were analyzed: 1140 at percutaneous coronary intervention hospitals and 923 at non-percutaneous coronary intervention hospitals. The Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments was associated with significant improvements in treatment times in women and the elderly, including door-to-ECG, door-to-device, door-in-door-out, and door-to-needle times (all PϽ0.05). Temporal improvements in treatment times at percutaneous coronary intervention hospitals were not significantly different in blacks than in whites. There was a reduction in baseline treatment disparities in door-to-ECG times in women versus men (4.4-minute reduction in difference; 95% CI, Ϫ8.1 to Ϫ0.4; Pϭ0.03). After Reperfusion of Acute Myocardial Infarction in North Carolina Emergency Departments, an age-treatment time gap persisted in the elderly, relative to younger patients. Conclusions-A statewide STEMI regionalization program was associated with comparable improvement in treatment times for female, black, and elderly patients compared with middle-aged, white male patients. Nevertheless, there remain opportunities to further narrow treatment differences, particularly among the elderly. (Circ Cardiovasc Qual Outcomes. 2010;3:514-521.)
D isparities in both the use and timing of reperfusion for acute ST-segment-elevation myocardial infarction (STEMI) have been shown in vulnerable patient subgroups, including minorities, women, and the elderly. [1] [2] [3] [4] [5] [6] Treatment delays in these subgroups have been demonstrated for
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patients receiving primary percutaneous coronary intervention (PCI) as well as for those receiving primary fibrinolysis at non-PCI centers. For example, among patients in the National Registry of Myocardial Infarction (NRMI) undergoing transfer for primary PCI, patients with the longest first-door-to-device treatment times (Ͼ4 hours) were more likely to be older, female, and nonwhite. 7 For several decades, inequalities in acute cardiovascular care have been well described in the medical literature. Although such research should have sensitized caregivers to these issues, contemporary evidence suggests that significant care disparities still remain. 8 Recent national efforts have focused on prompt recognition and treatment of STEMI, including geographic STEMI regionalization programs to integrate care between non-PCI and PCI-capable hospitals to minimize time to reperfusion. 9 -18 A number of these geographic STEMI regionalization programs have resulted in improved treatment times. The largest STEMI regionalization experience to date is Reperfusion of Acute Myocardial Infarction in North Carolina Emer-gency Departments (RACE). The RACE program was created in 2006 to coordinate STEMI care among emergency medical services agencies and 65 acute care hospitals throughout North Carolina. 9, 10 After implementation of RACE, median reperfusion times significantly improved, specifically, first-door-to-device and door-to-needle times in non-PCI hospitals and door-in to door-out times for patients transferred from non-PCI hospitals.
Despite the initial successes of STEMI regionalization programs, the degree to which implementation of regionalization can address the use and timeliness of reperfusion therapy in women, minorities, and the elderly has not been previously evaluated. As STEMI systems implement standard protocols for timely diagnosis and treatment that take into account sociodemographic characteristics, one would expect treatment differences to lessen. The objectives of the current study were to determine (1) whether the magnitude of improvement in STEMI treatment times associated with the RACE program was similar for women versus men, elderly versus younger patients, and blacks versus whites, and (2) whether there was a change in baseline differences in STEMI treatment times according to sex and age through the education of nurses, physicians, and emergency medical technicians and improved regional systems of care that were incorporated during the RACE initiative.
WHAT IS KNOWN
• Prior studies have demonstrated differences in time to reperfusion for STEMI in women, minorities, and the elderly, relative to their counterparts. Regionalization has been shown to improve overall STEMI treatment times. Whether women, the elderly, and minorities are equally likely to benefit from STEMI regionalization compared with middle-aged, white male patients has not been studied.
WHAT THE STUDY ADDS
• A statewide STEMI regionalization program was associated with comparable improvement in treatment times for women, black, and elderly patients compared with middle-aged, white male patients. There remain important opportunities to further reduce STEMI reperfusion times, particularly among the elderly.
Methods
This study analyzed data collected as part of the RACE program. The design and methods for this study and data collection have been previously published. 9, 10 In brief, the RACE program was a coordinated, statewide system of STEMI reperfusion therapy that was implemented in 2006. Five regions in North Carolina that covered approximately two thirds of the state's hospitals and population were chosen. These regions were specifically selected to provide broad geographic distribution, to include both rural and urban populations, and to follow established hospital networks and patient referral patterns. The RACE program involved 65 hospitals, including 10 PCI and 55 non-PCI hospitals. RACE focused on the coordination of each aspect of care from the initial emergency medical response to reperfusion itself, that is fibrinolytic therapy or primary PCI, whichever was most appropriate for a given setting. The program had institutional review board approval for analyses and publication of the findings. To collect data from all patients without needing to request informed consent, protected health information was removed before data collection, and the study was monitored by an independent oversight board. All PCI hospitals agreed to collect data for consecutive patients directly presenting or transferred to their centers according to the fifth NRMI. All hospitals allowed for an aggregate system report in the quarter before and the quarter after the 1-year intervention (preintervention data were collected for all consecutive patients hospitalized between July 1, 2005, and September 30, 2005, and postintervention data were collected for all consecutive patients hospitalized between January 1, 2007, and March 31, 2007) . All patients with STEMI were included as identified through emergency department, catheterization laboratory registration, and hospital discharge data.
The non-PCI hospitals participated in an abbreviated data collection process performed by regional coordinators for 10 consecutive patients with STEMI in the quarter preceding and after the RACE intervention period (preintervention data were collected up to 5 months before enrollment, with enrollment between July 2005 and March 2006, and postintervention data were collected between January 1, 2007, and March 31, 2007) .
Statistical Analysis
Analyses were performed to provide insight into the following 2 research questions: (1) the magnitude of improvement in STEMI treatment times from the pre-to postintervention periods stratified by sex (women vs men), race (black vs white), and age (Ͻ70 years vs Ն70 years) and (2) the change in differences in STEMI treatment times according to sex and age in the pre-and postintervention periods.
At PCI hospitals, we evaluated door-to-ECG times and door-todevice times. Among patients who were transferred in for PCI and those who presented directly to PCI hospitals, door-to-device times were evaluated separately. At non-PCI hospitals, we evaluated door-to-ECG times, door-to-needle times, and door-in-door-out times. Door-toneedle times were evaluated among patients who received thrombolytic therapy. Door-in-door-out times were evaluated among patients transferred out for primary PCI. Door-to-device and door-to-needle treatment times were evaluated as continuous variables.
Descriptive statistics for continuous variables are presented as median with interquartile range (IQR). Categorical variables are presented as frequency with percentage. Logarithmic transformation was performed for all continuous outcomes to reduce skewness. Mixed-effects models with random intercepts for each hospital were used to account for the clustering of patients within each hospital. Variables in the unadjusted models included the variable of interest (sex or age), a pre-or post-RACE indicator, and the interaction between the 2 variables. For the PCI hospital models, we adjusted for baseline characteristics previously identified to influence reperfusion times, including history of hypertension, prior MI, prior coronary artery bypass grafting, diabetes mellitus, hypotension at presentation, and arrival mode (walk-in vs emergency medical services for direct arrival). 19 -22 At non-PCI hospitals, we adjusted for patient demographics (age or sex) as well as the presence of cardiogenic shock (defined as systolic blood pressure Ͻ90 mm Hg) at presentation. Because non-PCI hospitals participated in an abbreviated data collection process, detailed patient past medical histories and race/ethnicity data were unavailable for these hospitals. In all models, we adjusted for age when sex was the variable of interest and vice versa. The interaction effects of sexϫage on change in treatment time were tested in all adjusted and unadjusted models. We also tested for interaction effects of timeϫsex, timeϫrace, and timeϫage in all models. To improve the interpretability of the modeling results, parametric bootstrapping methods with 10 000 replications were used to construct the confidence interval and point estimate in the original scale. 23 A probability value Ͻ0.05 was considered significant for all tests. All statistical analyses were performed with SAS software (version 9.2, SAS Institute, Cary, NC).
Results
A total of 2063 patients were included in this study: 1140 patients were treated at PCI hospitals and 923 were treated at non-PCI hospitals. Between July 1, 2005, and September 30, 2005 (preintervention period), 576 patients with acute STEMI were treated at PCI hospitals and 518 were treated at non-PCI hospitals. After the RACE intervention between January 1, 2007, and March 31, 2007 , the corresponding number of patients was 564 at PCI hospitals and 405 at non-PCI hospitals. Patient demographics, medical history, and presenting clinical characteristics for patients treated at PCI and non-PCI hospitals are shown in Table 1 . The overall characteristics of the patient populations were generally similar at both PCI and non-PCI hospitals during the pre-and postintervention periods.
Treatment times for men and women in both the pre-and post-RACE periods are displayed in Figures 1 (PCI hospitals) and 2 (non-PCI hospitals). Treatment times for patients Ͻ70 years and patients Ն70 years are displayed in Figures 3 (PCI hospitals) and 4 (non-PCI hospitals). After RACE, treatment times decreased for men and women at both PCI and non-PCI hospitals (Figures 1 and 2) . At PCI hospitals, median door-to-device times for direct arrivals decreased significantly for both men and women (men, 81 to 71 minutes, Pϭ0.02; women, 88 to 77 minutes, Pϭ0.05). Similarly, door-to-device times for transfer-ins numerically decreased for both men and women, although the improvements were not significant at the Pϭ0.05 level for women (men, 159 to 121 minutes, PϽ0.01; women, 165 to 133 minutes, Pϭ0.06). The timeϫ sex interaction terms were not significant, indicating that temporal improvements in treatment times in women and men were not significantly different.
At non-PCI hospitals, there were significant improvements in door-to-needle, door-in-door-out, and door-to-ECG times in both men and women. The largest improvements in treatment times were seen in women, for whom median door-to-needle times decreased from 42 to 30 minutes, median door-in-door-out times decreased from 124 to 65 minutes, and door-to-ECG times decreased from 15 to 8 minutes (all PϽ0.05).
The treatment times for patients age Ͻ70 years and age Ն70 years both before and after the RACE intervention at PCI and non-PCI hospitals are displayed in Figures 3 and 4 . *Race/ethnicity data not available (N/A); abbreviated data collection process by regional coordinators.
At PCI hospitals, median door-to-device times for direct arrivals and transfer-ins decreased significantly for younger patients (direct arrivals, 81 to 69 minutes, PϽ0.01; transferins, 150 to 124 minutes, PϽ0.01). Among older patients, there was a numeric decrease in median door-to-device times among direct arrivals, which was not statistically significant (direct arrivals, 97 to 86 minutes, Pϭ0.17). There was a significant decrease in median door-to-device times among transfer-in patients (173 to 147 minutes, Pϭ0.03). The timeϫage interaction terms were not significant, indicating that temporal improvements in all treatment times were not significantly different in patients Ͻ70 years versus Ն70 years. At non-PCI hospitals, door-to-ECG times, door-in-doorout, and door-to-needle times all improved significantly for both younger and older patients. The largest improvements in treatment times were seen in older patients. Among patients Ն70 years, median door-in-door-out times decreased from 117 to 76 minutes, door-to-ECG times decreased from 18 to 9 minutes, and door-to-needle times decreased from 48 to 36 minutes (all PϽ0.05).
No significant interaction effects of ageϫsex were identified in the unadjusted or adjusted models. Table 2 displays adjusted differences in treatment times between men and women in both the pre-and postintervention periods, as well as temporal changes in treatment time differences. Before RACE, there were no significant baseline differences in treatment times between women and men at PCI hospitals. However, at non-PCI hospitals, women had numerically longer door-to-ECG times (4.3 minutes longer; 95% CI, 0.8 to 7.3), door-in-door-out times (26.3 minutes longer; 95% CI, Ϫ6.1 to 50.0), and door-to-needle times (5.2 minutes longer; 95% CI, Ϫ3.2 to 12.8). The RACE program was associated with a significant reduction in the baseline difference in door-to-ECG time between men and women (Ϫ4.4 minutes; 95% CI, Ϫ8.1 to Ϫ0.4). There were also numeric reductions in treatment differences between men and women in door-in-door-out times (Ϫ25.0 minutes; 95% CI, Ϫ50.2 to 10.6) and door-to-needle times (Ϫ5.3 minutes; 95% CI, Ϫ16.3 to 5.8), although the changes were not statistically significant. Table 3 displays adjusted differences in treatment times between younger and older patients in both the pre-and postintervention periods. Also displayed are the temporal changes in treatment time differences associated with RACE. There were numeric reductions in baseline treatment differences between men and women in door-in-door-out times (Ϫ10.2 minutes; 95% CI, Ϫ39.4 to 24.5), door-to-needle times (Ϫ8.5 minutes; 95% CI, Ϫ21.6 to 4.7), and door-to-ECG times (Ϫ4.3 minutes; 95% CI, Ϫ8.5 to 0.1), although the changes were not statistically significant. At the conclusion of the RACE program, treatment disparities were noted in door-to-device times in patients Ն70 years (17.7 minutes longer; 95% CI, 5.4 to 28.0).
Among whites, median door-to-device treatment time for direct arrivals in the pre-RACE period was 84 minutes (IQR, 66 to 108; nϭ133) versus 73 minutes (IQR, 53 to 93; nϭ184) in the post-RACE period (PϽ0.01); median door-to-device treatment time for transfer-ins in the pre-RACE period was 160 minutes (IQR, 128 to 220; nϭ83) versus 125 minutes (IQR, 102 to 180; nϭ96) in the post-RACE period (PϽ0.01). Among blacks, median door-to-device treatment time for direct arrivals in the pre-RACE period was 83 minutes (IQR, 74 to 120; nϭ22) versus 74 minutes (IQR, 58 to 92; nϭ36) in the post-RACE period (Pϭ0.12); median door-to-device treatment time for transfer-ins in the pre-RACE period was 151 minutes (IQR, 119 to 180; nϭ11) versus 136 minutes (IQR, 101 to 192) in the post-RACE period (Pϭ0.59). The timeϫrace interaction terms were not significant, indicating that temporal improvements in treatment times were not significantly different in whites versus blacks. There was no significant temporal change in median door-to-ECG times in blacks or whites. Finally, reperfusion rates among eligible patients exceeded 95% during both the pre-and postintervention periods for all subgroups analyzed.
Discussion
Regionalization has been shown to improve overall STEMI treatment times, but its impact on care differences among these important patient subgroups is unknown. In this study, we found that women, minorities, and the elderly received comparable benefits relative to their counterparts from improved systems of care that were incorporated during the implementation of a statewide STEMI regionalization program. The RACE program was also associated with a significant reduction in baseline care differences in door-to-ECG times in women versus men.
Previous studies have highlighted significant disparities in acute cardiovascular care among women, minorities, and the elderly, including the overall use and timeliness of reperfusion therapy. For example, in a study of 350 000 patients in the NRMI, women were less likely to receive PCI and were treated with thrombolytic therapy an average of almost 14 minutes later than men. 24 At baseline, the RACE program confirmed known differences in adjusted treatment times among women and the elderly relative to their peers, including door-to-device times and door-to-needle times in the elderly, and door-to-ECG times in women. It is encouraging to note, however, that women, blacks, and the elderly experienced improvements comparable to their counterparts in treatment times. In addition, Ͼ95% of eligible women, blacks, and the elderly with STEMI in RACE received reperfusion therapy.
Several prior studies have examined the ability of STEMI regionalization programs to shorten reperfusion times for patients with acute STEMI. 10 -17 To date, however, those studies have not reported whether at-risk patients benefit (at all or in particular) from such programs. Several published studies in the surgical literature suggest that the regionalization of hepatic and pancreatic surgical care is associated with increasing disparities in the use of high-volume providers among the elderly and blacks. 25, 26 Those studies have also raised concerns that regionalization may be associated with worse outcomes among women and the elderly. In contrast, we found no evidence of preferential benefits of regionalization for middle-aged male patients; indeed, women and the elderly appear to derive benefit with regionalization, particularly at non-PCI hospitals. We did not find it surprising that systematic care may be of special benefit to patients with the most to gain (ie, populations with worse care at baseline). In this study, the largest relative improvements in treatment times in women and the elderly occurred at non-PCI hospitals. Hospitals lacking PCI facilities are generally smaller and more rural. Hospitals without PCI capability play a critical role in STEMI regionalization efforts, either by rapid identification and transfer of STEMI patients to a PCI-capable center or administration of rapid thrombolytic therapy when timely PCI cannot be achieved. Yet there are unique challenges in providing timely STEMI care at non-PCI hospitals. Rural hospitals have more limited resources than do their urban counterparts, as well as fewer standardized clinical protocols for acute MI care. 27 In addition, non-emergencytrained physicians provide more than half of all emergency department care in rural areas and, in some rural areas, on-site emergency department staffing is achieved exclusively with midlevel providers. 28, 29 Furthermore, smaller, non-PCI hospitals in the RACE system generally cared for a relatively small number of STEMI patients, on the order of 2 to 5 patients per month. This lack of experience contributed to a hesitation among staff members regarding the initiation of fibrinolysis and uncertainty about how to arrange for urgent coronary interventions at tertiary centers. RACE addressed these challenges by working directly with administrators, nurses, physicians, and technicians at each hospital to implement tailored coronary reperfusion plans. In this study, the RACE program was associated with a significant reduction in baseline disparities in door-to-ECG times between women and men. Additionally, we found a numeric reduction in baseline treatment differences in door-in-doorout times and door-to-needle times in both women and the elderly. This may have been a byproduct of the RACE program's focus on the rapid identification of STEMI patients, which included a concerted effort to educate emergency department providers about atypical clinical presentations in at-risk groups.
Although treatment times in the elderly improved after RACE, there were disparities in the care of geriatric patients in door-to-device times among direct arrivals at PCI hospitals, as well as door-to-needle and door-to-ECG times at non-PCI hospitals. This is consistent with several recent studies highlighting treatment disparities in acute cardiovascular care in the elderly. 1, 2, 8 Possible reasons for such treatment disparities include delayed identification of patients with STEMI, physicians withholding therapy because of potential safety concerns from interventions such as fibrinolysis and antiplatelet therapy, and patient preferences. 1, 30 Barriers to timely care in the elderly and potential interventions to reduce inequalities in their care represent a robust opportunity in future STEMI quality improvement efforts.
Although temporal improvements in treatment times were not significantly different in whites versus blacks, a larger, prospective evaluation of the impact of regionalization on racial disparities in STEMI care is needed. In a recent national evaluation of Ϸ200 000 patients whose data were reported by hospitals to the Hospital Quality Alliance, the difference in door-to-device times between blacks and whites narrowed from 18 minutes in 2004 to 2005 to 7 minutes in 2007 to 2008. 31 Regionalization hinges on emergency medical services providers to rapidly identify and transport such patients from local hospitals and homes to medical centers capable of performing PCI. Emergency medical services systems are funded and equipped on a local basis, such that patients served by systems in lower socioeconomic and underserved areas may be at greater risk for delays in care. 32 
Limitations
This study has several potential limitations. First, there was no regional or national comparator by which to judge the relative improvement in STEMI care. The NRMI registry closed in December 2006, before the postintervention data collection period. Comparison with NRMI reports was further limited by the lack of continuous data distribution availability and the reporting of treatment times in a rolling 12-month fashion. With these caveats in mind, a comparison with NRMI during a similar period suggests larger improvements with the RACE intervention. Second, because data from PCI hospitals were obtained from a voluntary registry and non-PCI hospital data were collected by independent study personnel, we cannot exclude the possibility of selection bias in the reporting of patient data. Nevertheless, the data collected in this study are consistent with overall estimates of STEMI prevalence in North Carolina.
Conclusions
A statewide STEMI regionalization program was associated with comparable improvement in treatment times for female, black, and elderly patients compared with middle-aged, white male patients. The RACE program was also associated with a reduction in baseline differences in care in women. Despite these improvements, there remain opportunities to further narrow treatment differences, particularly among the elderly. 
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